RIPE-KG · Version 1.1.0 · Resource

ripekg:work/RIPEW2F4EAF2DB393AAD4

https://w3id.org/ripe/ripe-kg/work/RIPEW2F4EAF2DB393AAD4
SubjectPredicateObject
ripekg:work/10.1016%2Fj.eururo.2013.04.001OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial http://purl.org/spar/cito/cites ripekg:work/RIPEW2F4EAF2DB393AAD4OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo-controlled trial
ripekg:work/RIPEW2F4EAF2DB393AAD4OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo-controlled trial dcterms:title OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo-controlled trial
ripekg:work/RIPEW2F4EAF2DB393AAD4OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo-controlled trial rdf:type node1
ripekg:work/RIPEW2F4EAF2DB393AAD4OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo-controlled trial rdf:type http://purl.org/spar/fabio/Work
ripekg:work/RIPEW2F4EAF2DB393AAD4OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo-controlled trial rdf:type rdfs:Resource
ripekg:work/RIPEW2F4EAF2DB393AAD4OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo-controlled trial rdf:type owl:Thing
ripekg:work/RIPEW2F4EAF2DB393AAD4OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo-controlled trial rdf:type prov:Entity
ripekg:work/RIPEW2F4EAF2DB393AAD4OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo-controlled trial rdf:type ripe:WorkWork